Top Articles - Real Estate

The headlines read that housing has bounced back and that sales have bottomed. Recently the Commerce Department reported that sales of new, single-family homes rose 3.4 percent in November. The government even revised the previous three months, showing stronger activity. The

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

national and local news reporters are all claiming housing is on the rebound. But has it?

The Devil is in the Details

The Census Bureau surveys home builders and specific housing starts. If a home is built and at some point goes under contract for sale, then it is conside

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ed sold. They do not go back and check if the sale actually went through.

So what happens when Lennar, the # 3 homebuilder, says the cancellation rates for home sales was running about 30% last quarter and KB Homes says their cancellation rate was 43%. Due to the way the Ce

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

sus Bureau performs their survey, they do not double count if the house sells at some point later to another person. In the long run, this method does not over or under count the estimate of the number of houses sold.

However, in the short run, as their web site explains "A

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

a result of our methodology, if conditions worsen in the marketplace and cancellations are high, sales would be temporarily overestimated." So when the existing home sales data seems to be showing that the market is bottoming, we need to recognize that there are significant

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

cancellations that are missing from the data. You can access the actual Census Bureau policy at the following link: http://www.census.gov/const/www/salescancellations.html

The headlines ar

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

missing the underlying trend. The cancellations in sales of new houses imply that sales are lower than being reported. It doesn't seem likely we have hit the bottom in new home sales.

What does History Tell Us?

We keep hearing that the bottom in housing is either here or

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

very near. But is it? If the reported sales are skewed, then how can we tell? Maybe a look at some history will give us some insight. Guerite Advisors provides some excellent analysis that is useful. In the previous seven cycles since 1959, housing starts have dropped an ave

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

age of 50.7% from peak to trough. Each time housing starts have fallen more than 25% from their most peak, a recession has followed. The only exception was the "credit crunch" of 1966-67 that ended in an economic contraction but not an official recession.

According to

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

f="http://www.guerite.com/" target="_blank">Guerite Advisors, shows housing starts have dropped 34% so far from their peak in January 2006. To get to the average we need to have another 20% drop in starts. This is another bad sign that contradicts the headlines.

Profess

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

r Robert Shiller of Yale, author of Irrational Exuberance: Second Edition, tracks housing prices, adjusted for

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

nflation, since 1890. This index is for existing houses and not new construction. It presents housing values in constant terms over 156 years, factoring out the effects of inflation. The benchmark was set to 100 in 1890. This means that a house that sold for $100,000 in 1890

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

inflation adjusted to today's dollars, receives a value of 100. The equivalent house that sold in 2006 for $199,999 would receive an index score of 199, or 99% above the price in 1890. Here is the link to Shiller's site: cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

blank">http://www.econ.yale.edu/~shiller/

Since 1997 the price index has risen 83%. Professor Shiller believes that the index is mean regressing, meaning that over time it tends to return to the mean from the extremes. It is easy to understand that the spike in home pri

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ces is substantially above the mean, no matter how you would calculate it.

What concerns me the most is the wide disparity between the price of houses and building costs. I would think this has to narrow over time. Either the price of houses comes down, or the cost of build

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ng a home goes up or some combination of the two. In any case, it implies that housing will face more difficult times.

The Case for Soft Landing in Housing

So what will mitigate the problems in housing and help it find a soft landing and then move up. In the past declines

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

n housing were accompanied by high unemployment, high interest rates and a general slow down in the economy. So far we have low unemployment and low interest rates long term interest rates. Even if unemployment were to rise in 2007, keep in mind that approximately 80% of the

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

US economy is in the service sector, which tends to experience fewer layoffs than the manufacturing sector during an economic slow down or recession.

The 10 year treasury rate, the primary index for mortgage rates, is still in a relatively low 4.6% area. As long as mortgage

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

rates stay relatively low, housing should be able to hold its own.

Conclusion

The headlines on housing sales are misleading in that they are based on data that is in accurate over the short term. Calling a bottom in housing on these misleading numbers gives a false sense t

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

at the industry is doing better than it is. Be careful making investment decisions on this data. There are factors that continue to push housing down further and there are factors that are helping to moderate the fall in housing. It will take time for this to work itself out

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/140031/toparticles-Where-is-the-Bottom-in-Housing.html">Where is the Bottom in Housing?</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/140031/toparticles-Where-is-the-Bottom-in-Housing.html]Where is the Bottom in Housing?[/url]

Are you using downline builders in your marketing efforts? If you're not, you should be.

Secured home loans provide financial support to person for fulfilling his dreams and desires. Briefly, secured home loans can be used for purchasing a house, financing a car, financing wedding, home improvements, higher education etc.

Now that the H1-B cap has been reached, what are the options for foreign workers? The H1-B cap was reached by the USCIS in an unprecedented speed this year. In years past, the cap was reached in almost two months for fiscal year of 2007 and in four months for fiscal year 2006. It is clear that there is a big incongruency between the existing foreign talent and the amount of available H1-B Visas. As a result, one should explore other sorts of work Visas for entering and working in the United States.

Tags

Links

Top Articles - Where is the Bottom in Housing?

Related Articles: